VeriMed provides proprietary technology and services to manage the supply chain for controlled substances. Its platform gives stakeholders — providers/doctors, wholesalers and pharmacists — access to HIPAA‑compliant patient data to help mitigate substance abuse and drug diversion. The system comprises four components: an information portal, a Patient Risk Assessment, a mail‑shipment pharmacy that uses data to reduce risky deliveries, and a blister pack that records date and time each pill is removed so physicians can verify use. Led by founder and CEO Philip Gaucher, the company intends to use the funding to commercialize its solutions. The company raised $3M in venture funding in the reported round. The round was led by Fortis Capital Holdings. The company could be located in Charlotte.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2013